A leading Controlled Release DDS company with a focus to  enhance the value of your existing assets (LCM) by offering superior efficacy and safety profiles, convenient to use, extended IP protection, and combination products

12 years product development effort resulted in rich post-POC pipelines for your fast commercialization

About 200 Subject-Matter-Experts and Scientists globally to help fulfill your unmet needs

Main Business

Applying proprietary and conventional technologies to develop new drug products (NDA)

Vision

To become a world leader in developing proprietary drug delivery technologies and in developing NDA products under 505(b)(2) regulatory pathway

Mission

To deliver value added products which are safer, more efficacious and better patient compliance to meet the unmet clinical needs

Value

Patient-first, Innovation, Ownership, Courage, Responsibility, Integrity

Goals

Provide new drug products to improve quality of life

Provide financial return for the stock holders

Provide a platform for employees to exert talent and to realize their dreams of developing new drug products

Provide financial freedom for employees to raise their families

Work mind-set

Find ways to success. Makes no excuses for failure

Expectation

OPL cares about human health. World sees OPL’s technology